Ahead of an advisory committee meeting this week, FDA reviewers raised no serious efficacy or safety concerns about Moderna's ...

The FDA informed healthcare providers about disruptions in the supply of stereotactic breast biopsy needles that will likely ...

Kennedy Jr. this week refused to release a cruise ship passenger exposed to hantavirus in early May from a quarantine ...

Legal and public health experts expressed concern about HHS Secretary Robert F. Kennedy Jr.'s scrutiny of a medical journal's ...

The FDA approved another opioid overdose reversal product for over-the-counter (OTC) use, the agency announced on Tuesday.

Infant mortality in the U.S. dropped to a new all-time low in 2025, according to preliminary government data. There were ...

An older Japanese American woman with advanced Alzheimer's disease experienced transient improvements in multiple domains ...

COVID-19 vaccines were associated with a lower risk of major adverse cardiovascular events (MACE), in addition to other ...

At the American Society of Clinical Oncology (ASCO) meeting, updated HER2CLIMB-05 findings on the addition of tucatinib ...

Two family medicine residency programs in the Seattle-Tacoma area are folding or downsizing, raising concerns about physician ...

Replacing two high-dose chemotherapy courses with blinatumomab (Blincyto) significantly improved event-free survival (EFS) in ...

DESTINY-11, that's the phase III trial that looked at a T-DXd-based regimen in the neoadjuvant setting, so that's in ...